p73ß, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells

International Journal of Oncology

Volumn 13, Issue 1, 1998, Pages 5-9

  Prabhu, Nitas ^a   Somasundaram, Kumaravel ^a   Satyamoorthy, Kapaettu ^b   Herlyn, Meenhard ^b   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Gene therapy; Human papillomavirus; p53; p73

Indexed keywords

PROTEIN P53; UBIQUITIN; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; LIGASE; NUCLEAR PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73; UBIQUITIN PROTEIN LIGASE;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CULTURE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; MAMMAL; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; UTERINE CERVIX CANCER; METABOLISM; PAPILLOMA VIRUS; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS INFECTION;

APOPTOSIS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; LIGASES; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTEIN BINDING; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; TUMOR VIRUS INFECTIONS; UBIQUITIN-PROTEIN LIGASES;

EID: 0031596434     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Curtin J, Lanciano RM and Kudelka AP: Cervical cancer. In: Cancer Management: A Multidisciplinary Approach. Pazdur R, Coia LR, Hoskins WJ and Wagman LD (eds). PRR Publishers, Inc., Huntington, NY, pp149-173, 1998.
2. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.
3. Prabhu NS, Blagosklonny MV, Zeng Y-X, Wu GS, Waldman T and El-Deiry WS: Suppression of cancer cell growth by adenovirus expressing p21WAF1/CIP1 deficient in PCNA interaction. Clin Cancer Res 2: 1221-1229, 1996.
4. Meng RD, Shin H, Prabhu NS, George DL and El-Deiry WS: Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression. Clin Cancer Res 4: 251-259, 1998.
5. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997.
6. Jost CA, Marin MC and Kaelin WG Jr: p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194, 1997.
7. Baker SJ, Markowitz S, Fearon ER, Willson JKV and Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
8. Satyamoorthy K, Soballe PW, Soans F and Herlyn M: Adenovirus infection enhances killing of melanoma cells by a mitotoxin. Cancer Res 57: 1873-1876, 1997.
9. Busby-Earle RM, Steel CM, Williams AR, Cohen B and Bird CC: p53 mutations in cervical carcinogenesis - low frequency and lack of correlation with human papillomavirus status. Br J Cancer 69: 732-737, 1994.
10. Scheffner M, Munger K, Byrne JC and Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88: 5523-5527, 1991.
11. Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF and Chang EH: The status of the p53 gene in human papillomavirus positive or negative cervical carcinoma cell lines. Carcinogenesis 13: 1273-1275, 1992.
12. Bar JK, Markowska J, Harlozinska A, Sedlaczek P, Nowak M and Roszak A: Relation between infection with human papilloma-viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix. Eur J Gynaecol Oncol 17: 283-285, 1996.
13. Hachisuga T, Matsuo N, Iwasaka T, Sugimori H and Tsuneyoshi M: Human papillomavirus and p53 overexpression in carcinomas of the uterine cervix, lower uterine segment and endometrium. Pathology 28: 28-31, 1996.
14. Kim KH and Kim YS: Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis. Yonsei Med J 36: 412-425, 1995.
15. Hwang ES, Naeger LK and diMaio D: Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene 12: 795-803, 1996.
16. Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, diPaolo JA, Peehl DM and Giaccia AJ: Selection of human cervical epithelial cells that possess reduced apoptolic potential to low oxygen conditions. Cancer Res 57: 4200-4204, 1997.
17. Pim D, Massimi P and Banks L: Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 15: 257-264, 1997.
18. Hamada K, Sakaue M, Alemany R, Zhang WW, Horio Y, Roth J and Mitchell MF: Adenovirus-mediated transfer of HPV. 16 E6/E7 antisense RNA to human cervical cancer cells. Gynaecol Oncol 63: 219-227, 1996.
19. Beer-Romero P, Glass S and Rolfe M: Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14: 595-602, 1997.
20. Crook T, Ludwig RL, Marston NJ, Willkomm D and Vousden KH: Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6. Virology 217: 285-292, 1996.
21. Medcalf EA and Milner J: Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620+ p53 conformation. Oncogene 8: 2847-2851, 1993.
22. Kovach JS, McGovem RM, Cassady JD, Swanson SK, Wold LE, Vogelstein B and Sommer SS: Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas. J Natl Cancer Inst 83: 1004-1009, 1991.
23. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA and Yung WKA: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56: 694-699, 1996.